Table 1.
Cancer Group, n (%) | Control Group, n (%) | Total, n (%) | p-Value | ||
---|---|---|---|---|---|
Gender | Females | 31 (44.0%) | 40 (56.0%) | 71 (100.0%) | 0.836 |
Males | 47 (58.0%) | 34 (42.0%) | 81 (100.0%) | ||
Total included | 78 (51.0%) | 74 (49.0%) | 152 (100.0%) | - | |
Cancer stage | I | 16 (21.0%) | - | - | - |
II | 37 (47.0%) | - | - | ||
III | 19 (24.0%) | - | - | ||
IV | 6 (8.0%) | - | - | ||
Cancer differentiation grade | 1 | 23 (29.0%) | - | - | - |
2 | 43 (55.0%) | - | - | ||
3 | 12 (15.0%) | - | - |
n—number of study participants.